510(k) Report

510(k) · Cleared

Recalled · Class II · 2015

Amphirion Deep 0.014 Otw Pta Balloon Catheter

K042624510(k) TraditionalCleared Jan 10, 2005105-day reviewClass II21 CFR 870.1250Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Invatec Innovative Technologies, S.R.L. · DQY Catheter, Percutaneous

Cleared on Jan 10, 2005 after a 105-day review. The FDA summary names its predicate without a number. 99 later devices descend from it. It has been recalled once.

Decided
Jan 10, 2005
Review
105 days
Class
Class II
Product code
DQY
Recalls
1
Predicates
0

99 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2006: 2 descendants cleared2015: 9 descendants cleared2005: 2 descendants cleared2009: 4 descendants cleared2010: 7 descendants cleared2007: 3 descendants cleared2012: 5 descendants cleared2011: 7 descendants cleared2013: 3 descendants cleared2017: 7 descendants cleared2023: 1 descendant cleared2008: 2 descendants cleared2026: 6 descendants cleared2014: 2 descendants cleared2020: 7 descendants cleared2016: 6 descendants cleared2022: 6 descendants cleared2021: 5 descendants cleared2019: 3 descendants cleared2025: 3 descendants cleared2024: 6 descendants cleared2018: 3 descendants cleared20052010201520202025
  1. This deviceK042624 Amphirion Deep 0.014 Otw Pta Balloon CatheterInvatec Innovative Technologies, S.R.L. · 2005
  2. Descendant · cites it directly · 52 of its ownK063657 Vascutrak Pta Dilation CatheterYmed, Inc. · 2006
  3. Descendant · 2 generations on · 48 of its ownK073025 Vascutrak II Pta Dilatation CatheterThermopeutix, Inc. Dba Ymed, Inc. · 2007
  4. Descendant · 3 generations on · 47 of its ownK082343 Vascutrak 2, Models: V14 and V18Ymed, Inc. · 2008
  5. Descendant · 4 generations on · 36 of its ownK103459 Vascutrak Pta Dilatation CatheterC.R. Bard, Inc. · 2010
  6. Descendant · 2 generations on · 32 of its ownK100303 Angiosculpt Pta Scoring Balloon Catheter Model 2039-Xxyy, 2076-Xxyy…Angioscore, Inc. · 2010

Showing 5 of 99 descendants. See all descendants

Descendants cleared per year

2005: 22006: 22007: 32008: 22009: 42010: 72011: 72012: 52013: 32014: 22015: 92016: 62017: 72018: 32019: 32020: 72021: 52022: 62023: 12024: 62025: 32026: 6
2005high 9 (2015) · low 1 (2023)2026

Most influential descendants

Showing 5 of 99 · See all
  • K063657Vascutrak Pta Dilation CatheterYmed, Inc. · 2006 · cites it directly52descendants
  • K073025Vascutrak II Pta Dilatation CatheterThermopeutix, Inc. Dba Ymed, Inc. · 2007 · 2 generations on48descendants
  • K082343Vascutrak 2, Models: V14 and V18Ymed, Inc. · 2008 · 3 generations on47descendants
  • K103459Vascutrak Pta Dilatation CatheterC.R. Bard, Inc. · 2010 · 4 generations on36descendants
  • K100303Angiosculpt Pta Scoring Balloon Catheter Model 2039-Xxyy, 2076-Xxyy, 2092-Xxyy, 2105-XxyyAngioscore, Inc. · 2010 · 2 generations on32descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K042624Amphirion Deep 0.014 Otw Pta Balloon CatheterInvatec Innovative Technologies, S.R.L.2005—
+1K063657Vascutrak Pta Dilation CatheterYmed, Inc.2006—
+2K073025Vascutrak II Pta Dilatation CatheterThermopeutix, Inc. Dba Ymed, Inc.2007—
+3K082343Vascutrak 2, Models: V14 and V18Ymed, Inc.2008—
+4K103459Vascutrak Pta Dilatation CatheterC.R. Bard, Inc.2010—
+2K100303Angiosculpt Pta Scoring Balloon Catheter Model 2039-Xxyy, 2076-Xxyy…Angioscore, Inc.2010—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200520
200620
200730
200820
200940
201070
201170
201250
201330
201420
201590
201660
201770
201830
201930
202070
202150
202260
202310
202460
202530
202660
FIG. 1 — Lineage of K042624, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

  1. #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Boston Scientific SYMMIETRY Small Vessel Balloon Dilatation Catheter
Named without a submission number
—
*—Cordis AVIATOR Peripheral Dilatation Catheter
Named without a submission number
—

What descends from it? (99)

See all 99

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K063657Vascutrak Pta Dilation CatheterYmed, Inc.200652
K083919Amphirion Deep 0.014 Otw Pta Balloon CatheterInvatec Innovative Technologies, S.R.L.200926
K050276Diver C.E. CatheterInvatec Innovative Technologies, S.R.L.200517
K102645Willow/Elm Pta Balloon Dilatation CatheterCreagh Medical, Ltd.20106
K142954PTA 14 Balloon Dilatation Catheter OTWTexasmedical Technologies, Inc.20150

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 23, 2015Class IIZ-0243-2016Equipment maintenanceMedtronic has discovered that select lots of the Amphirion Deep PTA Balloon Dilation Catheter have a potential breach in the pouch seal enclosing the sterilized product.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K063657 (Ymed, Inc., 2006) has gone furthest, with 52 descendants of its own.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQY

21in 2025

2007: 162008: 312009: 372010: 222011: 362012: 302013: 322014: 192015: 272016: 222017: 262018: 252019: 302020: 202021: 182022: 182023: 182024: 162025: 212026 (partial year): 11
2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007: 85 days median2008: 66 days median2009: 73 days median2010: 74 days median2011: 71 days median2012: 87 days median2013: 92 days median2014: 127 days median2015: 118 days median2016: 117 days median2017: 113 days median2018: 106 days median2019: 111 days median2020: 120 days median2021: 81 days median2022: 74 days median2023: 114 days median2024: 87 days median2025: 115 days median2026 (partial year): 30 days median
2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007: 62008: 122009: 172010: 322011: 62012: 22013: 36, 1 Class I2014: 32015: 32016: 22, 7 Class I2017: 82018: 22019: 12020: 22021: 22023: 172024: 12025: 1, 1 Class I2026 (partial year): 2, 1 Class I
2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007: 3132008: 4962009: 8192010: 1,2932011: 1,2112012: 1,1912013: 1,3522014: 1,4972015: 2,3372016: 2,2522017: 2,4892018: 2,8552019: 2,9022020: 2,8892021: 3,0062022: 2,6432023: 3,0492024: 3,1902025: 3,056
2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200716856313
2008316612496
2009377317819
20102274321,293
2011367161,211
2012308721,191
2013329236 (1)1,352
20141912731,497
20152711832,337
20162211722 (7)2,252
20172611382,489
20182510622,855
20193011112,902
20202012022,889
2021188123,006
2022187402,643
202318114173,049
2024168713,190
2025211151 (1)3,056
202611302 (1)—

What is it indicated for?

The AMPHIRION™ DEEP 0.014" OTW PTA Balloon Catheter is intended to dilate stenoses in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042624: Amphirion Deep 0.014 Otw Pta Balloon Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K042624

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026